Search & Analyze

IOL Chemicals And Pharmaceuticals Ltd.

180.00−4.85 (−2.62%)

BSE · 30 Oct, 4:01 PM

: ₹5,217.45 Cr
: 31.04
: 1,19,149
: ₹186.35 - ₹176.00
: ₹224.00 - ₹67.14

IOL Chemicals And Pharmaceuticals Ltd. (IOLCP) share price closed at ₹180.00 on the BSE on Friday, October 30, 2026, down by 2.62% from its of ₹184.85. In that session IOLCP reached a of 186.35 and of 176.00. The for the session was 180.05. The stands at 192.71 and is at 129.03. Looking at , the stock ended the session in Downtrend.

Stock Overview

₹186.35

₹184.85

₹180.05

₹192.71

Price 6.60% below

₹129.03

Price 39.50% above

Key Fundamentals

: 5,217.45 Cr₹5.22 Thousand Crore
: 5.73
: 31.04
: 2.80
: 63.47
: 332.51 Cr₹332.51 Crore
: 0.11 %
Sector
Industry: Pharmaceuticals & Drugs
: 7.90
: 0.07

Industry Comparison

Ratio	Company	Sector
	31.04	44.77
	0.07	0.20
	2.80	4.61
	1.73	1.81
	0.11 %	0.11 %
Operating Margin	11.60 %	19.15 %

Sector figures are the median of 154 listed Healthcare companies.

Peer Comparison

Name
SUN PHARMA. SUNPHARMA	1,778.25	38.91	4,26,661.74	0.90	1,995.07	-36.16%	16,198.71	11.88%	19.11
DIVI'S LAB. DIVISLAB	9,715.00	88.17	2,57,902.73	0.31	902.00	65.50%	3,080.00	27.80%	21.51
TORRENT PHAR TORNTPHARM	4,635.15	83.01	1,76,306.21	0.82	534.00	-9.64%	4,979.00	50.79%	19.27
LAURUSLABS LAURUSLABS	2,392.00	96.46	1,29,242.68	0.08	436.19	124.27%	2,206.37	33.44%	18.20
ZYDUSLIFE ZYDUSLIFE	1,244.00	27.50	1,24,089.48	0.08	990.20	-34.90%	8,017.00	21.96%	21.39
DR.REDDY'S DRREDDY	1,350.20	40.25	1,12,698.53	0.59	913.20	-31.69%	8,697.80	-1.48%	13.75
CIPLA LTD. CIPLA	1,380.00	38.48	1,11,488.55	0.94	851.51	-37.08%	7,403.93	-2.44%	16.00
IOL Chemicals And Pharmaceuticals Ltd. IOLCP	180.00	31.04	5,217.45	0.11	64.40	89.80%	756.26	37.08%	10.65

Quarterly Results

consolidated figures in ₹ Crores · Quarterly

Particulars	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	503.92	502.38	525.75	523.30	527.78	551.69	567.53	580.39	619.45	756.26
Expenses	454.40	451.27	484.18	476.43	465.03	489.55	510.45	523.11	526.98	652.77
	49.52	51.11	41.57	46.87	62.75	62.14	57.08	57.28	92.47	103.49
	9.83%	10.17%	7.91%	8.96%	11.89%	11.26%	10.06%	9.87%	14.93%	13.68%
	7.52	7.38	6.43	4.07	4.53	7.37	6.88	-5.92	1.84	8.18
Interest	3.41	2.15	4.12	4.46	4.03	4.23	3.48	3.63	3.21	3.64
	16.43	16.82	17.94	18.68	18.55	19.77	19.99	20.18	20.29	21.34
	37.20	39.52	25.94	27.80	44.70	45.51	40.49	27.55	70.81	86.69
	25.75%	24.16%	26.18%	26.15%	29.71%	25.44%	25.98%	25.30%	24.93%	25.71%
	27.62	29.97	19.15	20.53	31.42	33.93	29.97	20.58	53.16	64.40
	4.70	5.10	3.26	3.50	1.07	1.16	1.02	0.70	1.81	2.19

Profit & Loss

consolidated figures in ₹ Crores · Annual

Particulars	FY 2021-22 (Mar)	FY 2022-23 (Mar)	FY 2023-24 (Mar)	FY 2024-25 (Mar)	FY 2025-26 (Mar)
No of Months	12.00	12.00	12.00	12.00	12.00
INCOME :
	2,184.02	2,217.11	2,132.79	2,079.21	2,319.06
	2,184.02	2,217.11	2,132.79	2,079.21	2,319.06
EXPENDITURE :
Increase/Decrease in Stock	-52.30	-18.20	-38.25	33.51	-18.53
Raw Material Consumed	1,622.81	1,565.29	1,435.20	1,358.34	1,505.63
Power & Fuel Cost	78.18	131.98	149.05	114.93	154.93
Employee Cost	141.30	168.21	201.02	216.57	248.26
Other Manufacturing Expenses	36.86	43.07	47.67	47.39	58.85
General and Administration Expenses	5.12	6.54	9.01	8.10	6.16
Selling and Distribution Expenses	66.84	61.85	51.25	62.21	54.80
Miscellaneous Expenses	26.92	32.70	47.25	35.86	40.00
	1,925.73	1,991.44	1,902.20	1,876.91	2,050.10
Operating Profit (Excl OI)	258.29	225.67	230.59	202.30	268.96
	32.04	25.61	30.07	22.41	21.38
	290.33	251.28	260.66	224.71	290.34
Interest	8.29	16.47	16.10	14.76	14.55
PBDT	282.04	234.81	244.56	209.95	275.79
	43.26	46.16	62.91	71.99	80.23
Profit Before Taxation & Exceptional Items	238.78	188.65	181.65	137.96	195.56
Exceptional Income / Expenses	-13.93				-11.20
	224.85	188.65	181.65	137.96	184.36
Provision for Tax	57.18	49.51	47.22	36.89	46.72
	167.67	139.14	134.43	101.07	137.64
Extra items				0.00	0.00
Consolidated Net Profit	167.67	139.14	134.43	101.07	137.64
Profit Balance B/F	971.31	1,103.76	1,219.40	1,324.48	1,402.07
Appropriations	1,138.98	1,242.90	1,353.83	1,425.55	1,539.71
Equity Dividend %	40.00%	40.00%	50.00%	40.00%	10.00%
	28.56	23.70	22.90	3.44	4.69
Adjusted EPS	5.71	4.74	4.58	3.44	4.69

Balance Sheet

consolidated figures in ₹ Crores

Particulars	FY 2021-22 (Mar)	FY 2022-23 (Mar)	FY 2023-24 (Mar)	FY 2024-25 (Mar)	FY 2025-26 (Mar)
	58.71	58.71	58.71	58.71	58.71
Total Reserves	1,333.57	1,449.01	1,552.80	1,628.95	1,739.84
Reserve excluding Revaluation Reserve	1,333.57	1,449.01	1,552.80	1,628.95	1,739.84
	1,392.28	1,507.72	1,611.51	1,687.66	1,798.55
Deferred Tax Assets / Liabilities	53.18	56.36	66.14	77.81	84.86
Other Long Term Liabilities	0.43	0.14	0.04		2.40
Long Term Provisions	3.01	1.65	6.71	6.69	10.96
Total Non-Current Liabilities	56.62	58.15	72.89	84.50	98.22
Trade Payables	409.29	314.22	469.18	427.56	482.56
Other Current Liabilities	54.02	54.28	54.67	63.34	69.85
Short Term Borrowings	42.75	79.63	32.76	117.04	132.00
Short Term Provisions	69.23	54.39	40.49	30.64	49.08
Total Current Liabilities	575.29	502.52	597.10	638.58	733.49
Total Liabilities	2,024.19	2,068.39	2,281.50	2,410.74	2,630.26
Gross Block	761.99	995.24	1,235.97	1,544.27	1,632.08
Less: Accumulated Depreciation	201.35	243.43	302.84	373.56	450.51
	560.64	751.81	933.13	1,170.71	1,181.57
	102.03	81.40	99.83	20.81	93.61
Non Current Investments		17.41	17.41	17.41	17.41
Long Term Investment		17.41	17.41	17.41	17.41
Long Term Loans & Advances	10.77	9.52	23.62	12.15	19.74
Other Non Current Assets	204.87	233.36	49.60	8.53	45.06
Total Non-Current Assets	881.48	1,101.74	1,124.63	1,230.73	1,359.32
Currents Investments	2.37	2.56	2.88	3.30	3.51
Inventories	409.89	325.52	424.84	360.62	371.07
Sundry Debtors	469.80	505.28	471.23	513.69	603.13
Cash and Bank	139.99	21.83	142.89	208.15	198.36
Other Current Assets	30.99	29.86	24.91	26.92	30.10
Short Term Loans and Advances	89.67	81.60	90.12	67.33	64.77
Total Current Assets	1,142.71	966.65	1,156.87	1,180.01	1,270.94
Net Current Assets (Including Current Investments)	567.42	464.13	559.77	541.43	537.45
Total Assets	2,024.19	2,068.39	2,281.50	2,410.74	2,630.26
	0.18	5.35	6.08	5.52	5.66
Total Debt	42.75	79.63	32.76	117.04	132.00
	237.15	256.81	274.49	57.49	61.27
Adjusted Book Value	47.43	51.36	54.90	57.49	61.27

Cash Flow

consolidated figures in ₹ Crores

Particulars	FY 2021-22 (Mar)	FY 2022-23 (Mar)	FY 2023-24 (Mar)	FY 2024-25 (Mar)	FY 2025-26 (Mar)
No of Months	12.00	12.00	12.00	12.00	12.00
	224.85	188.65	181.65	137.96	184.36
Adjustment	33.12	44.41	59.82	79.85	85.04
Changes In working Capital	-102.34	-63.69	90.33	-20.87	-17.22
Cash Flow after changes in Working Capital	155.63	169.37	331.80	196.94	252.18
Cash Flow from Operating Activities	93.05	122.27	289.78	178.62	214.32
Cash Flow from Investing Activities	-120.52	-120.00	-190.98	-154.18	-198.11
Cash Flow from Financing Activitie	-1.64	-4.11	-92.50	46.04	-29.03
Net Cash Inflow / Outflow	-29.11	-1.84	6.30	70.48	-12.82
Opening Cash & Cash Equivalents	32.34	3.23	1.39	7.69	78.17
Closing Cash & Cash Equivalent	3.23	1.39	7.69	78.17	65.35

Ratios

Valuation

31.04

2.80

15.49

2.07

5.73

63.47

Profitability

7.90

10.65

5.46

11.60

5.94

Leverage & Liquidity

0.07

1.73

13.67

Returns

0.11

0.92

Shareholding Pattern

Numbers in percentages

Particulars	Jun '24	Sep '24	Dec '24	Mar '25	Jun '25	Sep '25	Dec '25	Mar '26	Jun '26	Sep '26
	48.19	48.19	52.62	52.62	52.62	52.62	52.62	57.48	62.28	62.28
	1.48	1.70	1.56	1.54	2.61	2.29	2.10	1.74	5.30	7.56
	50.34	50.11	45.82	45.84	44.77	45.09	45.28	40.78	32.42	30.17
	51.81	51.81	47.38	47.38	47.38	47.38	47.38	42.52	37.72	37.72
No. of Shareholders	1,28,689	1,25,979	1,26,701	1,30,002	1,25,040	1,36,129	1,33,531	1,31,550	1,19,311	1,32,241

Mutual Funds Invested(4)

Based on each fund's latest monthly portfolio · Sep 2026

A total of 1 active fund holds 0.27% in IOL Chemicals And Pharmaceuticals Ltd., contributing to ₹16 Cr of holdings

Fund				As of
UN Union Active Momentum Fund - Growth - Direct PlanEquity - Thematic Fund - Other	16.43	3.03	7,93,498	Sep '26
MO Motilal Oswal BSE Healthcare ETFIndex	0.06	0.15	3,108	Sep '26
ID Bandhan BSE Healthcare Index Fund - Growth - Direct PlanIndex Funds - Other	0.03	0.15	1,465	Sep '26
MO Motilal Oswal BSE 1000 Index Fund - Growth - Direct PlanIndex Funds - Other	0.01	0.01	329	Sep '26

Corporate Actions

Showing: All

Date	Type	Details
2026-10-23	Board Meeting	Quarterly Results
2026-08-03	Board Meeting	Quarterly Results
2026-05-20	AGM

Insider Trading

Date	Person	Category	Transaction Type	Shares	Value (₹)

No insider trading data available.

Sector Overview

HealthcarePharmaceuticals & Drugs

IOL Chemicals And Pharmaceuticals Ltd. operates in the Healthcare sector under the Pharmaceuticals & Drugs industry. This sector is one of the key drivers of the Indian economy and is closely tracked by the relevant Nifty sectoral index.

Company Profile

Corporate information and contact details

Key Management

9 members across the board and senior leadership

Rajender Mohan Malla

Chairman

₹4.50 L

Mar '26

Vikas Gupta

Joint Managing Director

₹3.49 Cr

Mar '26

Varinder Gupta

Managing Director

₹11.41 Cr

Mar '26

Abhiraj Gupta

Whole Time Director

₹1.66 Cr

Mar '26

Kushal Kumar Rana

Whole Time Director - Works

₹1.96 Cr

Mar '26

Harpal Singh

Non Executive Independent Director

₹8.50 L

Mar '26

Rajni Jha

Non Executive Independent Director

₹6.50 L

Mar '26

Sharad Tyagi

Non Executive Independent Director

₹11.50 L

Mar '26

Abhay Raj Singh

Senior Vice President & Company Secretary, Compliance Officer

—

IOLCP Latest News

News

1 of 1 article

EQUITY20 May 2026 · 14:36

IOL Chem & Pharma reports Profit after tax of Rs 531.80 Mln, in the March 2026 quarter

IOL Chemicals And Pharmaceuticals Ltd.

Stock Overview

Price chart

Peer Comparison

Quarterly Results

Profit & Loss

Balance Sheet

Cash Flow

Ratios

Valuation

Profitability

Leverage & Liquidity

Returns

Shareholding Pattern

Mutual Funds Invested(4)

Corporate Actions

Insider Trading

Sector Overview

Company Profile

Key Management

IOLCP Latest News

News